{"symbol":"LLY","fiscalQuarter":"Q4-2008","reportDate":"2009-01-29","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q4-2008","postBrief":{"headline":"Eli Lilly Beats on EPS, Stock Down 2.87%","keyNumbers":[{"metric":"EPS","actual":"$1.07","expected":"N/A","surprise":"+1.81%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted the importance of ongoing product development.","They expressed confidence in their pipeline despite current market challenges."],"summary":"Overall, management conveyed a sense of cautious optimism regarding future growth. They emphasized their commitment to innovation and navigating market conditions."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Eli Lilly's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by 2.87%, likely due to the absence of revenue details and guidance, which left investors uncertain about future performance. The cautious tone from management may also have contributed to the stock's decline.","metaDescription":"Eli Lilly (LLY) Q4 2008 earnings: EPS beat by 1.81%, revenue not disclosed. Stock down 2.87%. Full breakdown."}}